Poma 2 mg Capsule

उत्पाद विवरण

Poma 2 mg Capsule is a targeted anticancer treatment classified as an immunomodulatory agent, specifically designed for patients battling multiple myeloma, a challenging form of blood cancer. This medication is typically prescribed for individuals who have undergone at least two prior therapies, including treatments with lenalidomide and a proteasome inhibitor, making it a crucial option for those seeking further therapeutic avenues. By enhancing the immune response, Poma works to inhibit the growth of cancer cells, offering hope to those with relapsed or refractory disease. It is essential to be aware of potential side effects, which may include fatigue, nausea, and an increased risk of infection, highlighting the importance of regular monitoring during treatment. Patients should inform their healthcare provider of any existing conditions or medications, as interactions can occur. While Poma can significantly improve treatment outcomes, it is not suitable for everyone, necessitating a comprehensive evaluation by a healthcare professional. With its innovative approach, Poma 2 mg Capsule represents a vital tool in the ongoing fight against multiple myeloma, aiming to improve the quality of life for those affected by this condition.